Efficacy of mobile phone SMS reminders on malaria treatment adherence and post-treatment review (SMS-RES-MAL) in Kenya: a randomized controlled trial

niversity of Oxford (UK)0 个研究点目标入组 2,000 人开始时间: 2014年1月22日最近更新: 2017年2月20日

适应症

试验速览

暂无简介。

•1. Caregivers of male and female children aged < 5 years old
•2. Body weight eligibility for artemether-lumefantrine (AL)
•3. Microscopically confirmed, mono-infection of Plasmodium falciparum (parasitaemia = 500/µL to 200,000/µL)
•4. History of fever in the last 24 hours or presence of fever (axillary temperature = 37.5 °C)
•5. Network coverage at patients? household
•6. Owning a mobile phone or have shared access to a mobile phone in household
•7. Ability to access a mobile phone on a daily basis for the period of follow up
•8. Ability to open and read short message service (SMS)
•9. Written informed consent

•1. Caregivers not owning a mobile phone and have no shared access to any phone in the household
•2. Severe malaria
•3. Danger signs: not able to drink or breast-feed, vomiting (> twice in 24hours), recent history of convulsions (>1 in 24h), unconscious state, unable to sit or stand
•4. Presence of concomitant illness or any condition which in the judgement of the investigator would place the subject at undue risk or interfere with assessment
•5. Severe malnutrition (weight for height < 70 % of the median NCHS/WHO reference)
•6. Ongoing prophylaxis with drugs having antimalarial activity such as cotrimoxazole for the prevention of pneumocysti carini pneumonia in children born to HIV+ women
•7. Having taken AL in the previous one month

发起方

niversity of Oxford (UK)